Demonstrating the Value of Early Biocatalysis Adoption to Overcome Risk Aversion & Secure Internal Buy-In

  • Learn how to position biocatalysis as a low-risk, high-impact strategy early in development
  • Understand common barriers to adoption, including organization inertia and chemistry bias
  • Explore approaches to justify early investment despite uncertain project outcomes